Arthur C.  Butcher net worth and biography

Arthur Butcher Biography and Net Worth

Arthur C. Butcher is our executive vice president and president, Asia Pacific, a position he has held since February 2020. In this role, he is responsible for commercialization of our full portfolio of products across all divisions in the Asia Pacific region. Prior to his current role, Mr. Butcher served as our senior vice president and president, Endoscopy, a position he held from July 2016 until February 2020. In this role, he was responsible for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions. He also served as vice president & general manager, Japan Endoscopy from August 2014 to June 2016. Mr. Butcher has held a variety of marketing and strategic planning management positions within the Endoscopy and Urology and Pelvic Health businesses, including vice president of global marketing, Endoscopy division from April 2011 to August 2014, and vice president of new business development and strategic planning, Urology & Women’s Health. Since joining Boston Scientific in 1997, Mr. Butcher has held management roles with increasing responsibility and has deep experience across divisions. Mr. Butcher currently is a member of our Global Council for Inclusion. He holds a B.A. in International Relations from the University of Pennsylvania and an M.B.A. from Columbia University.

What is Arthur C. Butcher's net worth?

The estimated net worth of Arthur C. Butcher is at least $626,210.20 as of August 21st, 2023. Mr. Butcher owns 11,396 shares of Boston Scientific stock worth more than $626,210 as of December 10th. This net worth approximation does not reflect any other investments that Mr. Butcher may own. Additionally, Mr. Butcher receives an annual salary of $1,400,000.00 as EVP at Boston Scientific. Learn More about Arthur C. Butcher's net worth.

How old is Arthur C. Butcher?

Mr. Butcher is currently 52 years old. There are 7 older executives and no younger executives at Boston Scientific. The oldest executive at Boston Scientific is Mr. Joseph M. Fitzgerald, Executive VP & Group President of Cardiology, who is 59 years old. Learn More on Arthur C. Butcher's age.

What is Arthur C. Butcher's salary?

As the EVP of Boston Scientific Co., Mr. Butcher earns $1,400,000.00 per year. There are 3 executives that earn more than Mr. Butcher. The highest earning executive at Boston Scientific is Mr. Michael F. Mahoney, Chairman, President & CEO, who commands a salary of $3,770,000.00 per year. Learn More on Arthur C. Butcher's salary.

How do I contact Arthur C. Butcher?

The corporate mailing address for Mr. Butcher and other Boston Scientific executives is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. Boston Scientific can also be reached via phone at (508) 683-4000 and via email at [email protected]. Learn More on Arthur C. Butcher's contact information.

Has Arthur C. Butcher been buying or selling shares of Boston Scientific?

Arthur C. Butcher has not been actively trading shares of Boston Scientific within the last three months. Most recently, Arthur C. Butcher sold 6,600 shares of the business's stock in a transaction on Monday, August 21st. The shares were sold at an average price of $50.40, for a transaction totalling $332,640.00. Following the completion of the sale, the executive vice president now directly owns 11,396 shares of the company's stock, valued at $574,358.40. Learn More on Arthur C. Butcher's trading history.

Who are Boston Scientific's active insiders?

Are insiders buying or selling shares of Boston Scientific?

During the last twelve months, insiders at the medical equipment provider sold shares 28 times. They sold a total of 787,517 shares worth more than $40,703,431.02. The most recent insider tranaction occured on December, 6th when EVP Jeffrey B Mirviss sold 353 shares worth more than $19,425.59. Insiders at Boston Scientific own 0.7% of the company. Learn More about insider trades at Boston Scientific.

Information on this page was last updated on 12/6/2023.

Arthur C. Butcher Insider Trading History at Boston Scientific

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2023Sell6,600$50.40$332,640.0011,396View SEC Filing Icon  
6/21/2023Sell6,697$53.80$360,298.6017,453View SEC Filing Icon  
3/23/2023Sell6,703$47.97$321,542.9122,981View SEC Filing Icon  
2/3/2023Sell27,000$48.74$1,315,980.0023,392View SEC Filing Icon  
4/15/2021Sell9,676$40.00$387,040.0039,074View SEC Filing Icon  
11/8/2019Sell1,104$40.75$44,988.00View SEC Filing Icon  
8/15/2019Sell6,329$41.98$265,691.42View SEC Filing Icon  
2/21/2019Sell15,225$39.95$608,238.75View SEC Filing Icon  
11/9/2018Sell4,000$38.50$154,000.00View SEC Filing Icon  
5/10/2018Sell7,500$30.06$225,450.0012,484View SEC Filing Icon  
See Full Table

Arthur C. Butcher Buying and Selling Activity at Boston Scientific

This chart shows Arthur C Butcher's buying and selling at Boston Scientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Boston Scientific Company Overview

Boston Scientific logo
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Read More

Today's Range

Now: $54.95
Low: $54.52
High: $55.05

50 Day Range

MA: $52.69
Low: $48.64
High: $56.14

2 Week Range

Now: $54.95
Low: $44.35
High: $56.22


4,300,356 shs

Average Volume

6,064,972 shs

Market Capitalization

$80.50 billion

P/E Ratio


Dividend Yield